Association of Tirzepatide versus Glucagon-Like Peptide-1 Receptor Agonists with Incident Glaucoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study.

This association remained consistent across multiple sensitivity analyses, including the exclusion of individuals with early primary open-angle glaucoma events after the index date, restricting the cohort to patients with ≥1 subsequent prescription during follow-up, an intention-to-treat design, and limiting the analysis exclusively to individuals with an ophthalmology visit.